Correspondence
Corresponding with elected officials, agency appointees, and even the current administration, is just one way take our message right to the heart of public policy. Below, you can explore some of our recent sign-on letters.
ACS CAN & NCCN Joint Cancer Moonshot Letter to the Hill
HOPA's correspondence letter to Congresses 2022 congressional leaders, details HOPA's dedication to President Biden's re-igniton of the Joint Cancer Moonshot program.
CLC Principles for the Advanced Research Projects Agency for Health (ARPA-H) - July 2021
Read about key principals curated from the Cancer Leadership Council (CLC) on the Advanced Research Projects Agency for Health. The CLC details guidance on organizational independence and project selection standards.
HPNEC FY23 End of Year Appropriations Request EOY Letter
HOPA's correspondence letter to the Appropriations committee on behalf of the Health Professions and Nursing Education Coalition (HPNEC). HOPA urges congressional leaders to provide funding levels for the Nursing Workforce Development programs.
Joint Letter on Confirmation of Dr. Robert Califf FDA Commissioner
HOPA's letter of support for the confirmation of Dr. Robert Cliff as the FDA Commisioner based on his commitment to science based decisions.
Joint Pharmacy Request for PREP Act Declaration for Monkeypox
Read a correspondence supporting a request to amend the declaration of a monkeypox Public Health Emergency to identify pharmacists, pharmacy students and pharmacy technicians as qualified persons covered under the PREP Act.
Patient Community AKACA Support Letter
A correspondence on behalf of 28 organizations in support of the Accelerating Kids’Access to Care Act.
Pharmacy Coalition Letter to HHS - DIR Part D Proposed Rule
A correspondence on behalf of patients, pharmacies, health care organizations, and health care practitioners, we write to urge the Department of Health and Human Services (HHS) to move forward with a proposal in the Centers for Medicare & Medicaid Services (CMS).
PHIT Comments on Cybersecurity in Medical Devices
Comments submitted on behalf of the membership of the Pharmacy Health Information Technology Collaborative (PHIT), in relation to Docket No. FDA-2021-D-1158.
PHIT Comments on Cybersecurity in Medical Devices
Read HOPA's correspondence to congressional leaders in an effort to safeguard American's access to COVID-19 testing.